PDF
Summary: Interim guidance on the use of bivalent Omicron-containing COVID-19 vaccines for primary series
Organization: Public Health Agency of Canada (PHAC)Published: 2023
NACI now recommends that: When mRNA COVID-19 vaccines are used for the primary series, bivalent Omicron-containing vaccines can be used in individuals 6 months of age and over. (June 9, 2023)
Resource Group:
Implementation Tool
Product Type: Guide
Outbreaks and Pandemics
COVID-19
Program Planning and Delivery
Program Delivery and Evaluation
Clinics
Product Type: Guide
Category:
Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19,Program Planning and Delivery,Program Delivery and Evaluation,Clinics Monitoring and SurveillanceOutbreaks and Pandemics
COVID-19
Program Planning and Delivery
Program Delivery and Evaluation
Clinics
Region:
National
Language:
English
Resource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.